A new Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2024 commences today, Friday 1 March 2024.

This technical alert provides members with a summary of changes as well as a comparison table of all changes to the Determination.

Important changes in this Determination include:

NEW ingredients for use in listed and assessed listed medicines and specific requirements that apply to those ingredients:

- Addition of the new active ingredient theanine with exclusive use provisions for 2 years;

-Addition of the new excipient ingredient ceramide 6 II;

Addition of the new excipient ingredient sodium lauroyl lactylate; 

CHANGED ingredients including ingredients with NEW WARNINGS and other changed requirements:

- Curcuma aromatica; Curcuma longa (Turmeric); Curcuma zanthorrhiza; Curcuma zedoaria; and curcumin.

- Camellia sinensis (Green tea).

Ingredients with important changed requirements including

- Terminalia ferdinandiana (Kakadu plum); neohesperidin-dihydrochalcone (permitted for oral use in listed and listed assessed medicines); hemp seed oil, and other ingredients.

Please read today’s full alert for more details.